The Lithuanian Competition Authority accepts commitments from eight pharmaceutical companies after an investigation into a possible anticompetitive vertical agreement (Berlin Chemie Menarini Baltic / GlaxoSmithKline Lietuva / Fresenius Kabi Polska / Viasana / Nutricia Baltics)

Lithuania: The Competition Council accepts Commitments by eight pharmaceutical Companies* On 21 July 2011, the Lithuanian Competition Council (the CC) closed an investigation into possible anticompetitive vertical agreements between producers/suppliers and wholesalers of pharmaceuticals with regard to their participation in public procurement tenders, following commitments proposed by the said companies. Based on the information provided by the Ministry of Health of the Republic of Lithuania, the CC conducted an investigation into the

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

Quotation

European Competition Network Brief, The Lithuanian Competition Authority accepts commitments from eight pharmaceutical companies after an investigation into a possible anticompetitive vertical agreement (Berlin Chemie Menarini Baltic / GlaxoSmithKline Lietuva / Fresenius Kabi Polska / Viasana / Nutricia Baltics), 21 July 2011, e-Competitions Bulletin Competition in the Pharmaceutical sector, Art. N° 40431

Visites 389

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues